Modeling the direct effects of TNFα upon drug-induced toxicity with in human, tissue-engineered myobundles.

<p>A number of significant muscle diseases, such as cachexia, sarcopenia, systemic chronic inflammation, along with inflammatory myopathies share TNFα-mediated inflammation in their pathogenesis. TNFα-based inflammatory stress may directly sensitize skeletal muscle to drug-induced toxicity. Th...

Full description

Bibliographic Details
Main Author: Davis, Brittany
Other Authors: Truskey, George A
Published: 2016
Subjects:
Online Access:http://hdl.handle.net/10161/13357
id ndltd-DUKE-oai-dukespace.lib.duke.edu-10161-13357
record_format oai_dc
spelling ndltd-DUKE-oai-dukespace.lib.duke.edu-10161-133572017-01-06T03:36:29ZModeling the direct effects of TNFα upon drug-induced toxicity with in human, tissue-engineered myobundles.Davis, BrittanyBiomedical engineering<p>A number of significant muscle diseases, such as cachexia, sarcopenia, systemic chronic inflammation, along with inflammatory myopathies share TNFα-mediated inflammation in their pathogenesis. TNFα-based inflammatory stress may directly sensitize skeletal muscle to drug-induced toxicity. The two main difficulties when assessing the role of TNFα on skeletal muscle drug toxicity using in vitro methodology are first creating an experimental model that recapitulates the basal functional responses of human skeletal muscle and second validating that the experimental model accurately represents human skeletal muscle response to TNFα. The aim of this research is to resolve these two difficulties. </p><p>We first assayed the bioenergetic profile of engineered three-dimensional human skeletal muscle myobundles to probe mitochondrial health and compared its result to muscle fatigue. Then engineered a perfusion system to measure respiration under basal conditions and electrical stimulation. Finally, to assess the effect of TNFα-induced inflammation on drug responses, we engineered 3D, human skeletal myobundles, chronically exposed them the TNFα during maturation, and measured the combined response of TNFα and the chemotherapeutic, doxorubicin, on muscle function. We concluded that the human myobundles reproduce normal muscle metabolism under both basal and maximal energy demand conditions enabling the detection of drug-induced mitochondrial toxicity. The bioenergetic health index, which is a measure of normal oxidative mitochondrial function, was inversely correlated with the extent of fatigue. The relationship between mitochondrial function and physiological muscle function suggests that the mitochondrial dysfunction produced the fatigue. The custom perfusion chamber was validated to accurately measure oxygen uptake during basal and electrical stimulation conditions. This in vitro non-invasive tool enables the investigation of human muscle physiology during exercise. Utilizing the myobundle platform, a synergistic effect of the combination of TNFα and 10nM doxorubicin was found on contractile force production. Overall, we demonstrated the feasibility of the in vitro 3D, human muscle inflammatory system to act as a drug-toxicity testing platform and validated assays to quantify drug-induced decrements in mitochondrial function.</p>DissertationTruskey, George A2016Dissertationhttp://hdl.handle.net/10161/13357
collection NDLTD
sources NDLTD
topic Biomedical engineering
spellingShingle Biomedical engineering
Davis, Brittany
Modeling the direct effects of TNFα upon drug-induced toxicity with in human, tissue-engineered myobundles.
description <p>A number of significant muscle diseases, such as cachexia, sarcopenia, systemic chronic inflammation, along with inflammatory myopathies share TNFα-mediated inflammation in their pathogenesis. TNFα-based inflammatory stress may directly sensitize skeletal muscle to drug-induced toxicity. The two main difficulties when assessing the role of TNFα on skeletal muscle drug toxicity using in vitro methodology are first creating an experimental model that recapitulates the basal functional responses of human skeletal muscle and second validating that the experimental model accurately represents human skeletal muscle response to TNFα. The aim of this research is to resolve these two difficulties. </p><p>We first assayed the bioenergetic profile of engineered three-dimensional human skeletal muscle myobundles to probe mitochondrial health and compared its result to muscle fatigue. Then engineered a perfusion system to measure respiration under basal conditions and electrical stimulation. Finally, to assess the effect of TNFα-induced inflammation on drug responses, we engineered 3D, human skeletal myobundles, chronically exposed them the TNFα during maturation, and measured the combined response of TNFα and the chemotherapeutic, doxorubicin, on muscle function. We concluded that the human myobundles reproduce normal muscle metabolism under both basal and maximal energy demand conditions enabling the detection of drug-induced mitochondrial toxicity. The bioenergetic health index, which is a measure of normal oxidative mitochondrial function, was inversely correlated with the extent of fatigue. The relationship between mitochondrial function and physiological muscle function suggests that the mitochondrial dysfunction produced the fatigue. The custom perfusion chamber was validated to accurately measure oxygen uptake during basal and electrical stimulation conditions. This in vitro non-invasive tool enables the investigation of human muscle physiology during exercise. Utilizing the myobundle platform, a synergistic effect of the combination of TNFα and 10nM doxorubicin was found on contractile force production. Overall, we demonstrated the feasibility of the in vitro 3D, human muscle inflammatory system to act as a drug-toxicity testing platform and validated assays to quantify drug-induced decrements in mitochondrial function.</p> === Dissertation
author2 Truskey, George A
author_facet Truskey, George A
Davis, Brittany
author Davis, Brittany
author_sort Davis, Brittany
title Modeling the direct effects of TNFα upon drug-induced toxicity with in human, tissue-engineered myobundles.
title_short Modeling the direct effects of TNFα upon drug-induced toxicity with in human, tissue-engineered myobundles.
title_full Modeling the direct effects of TNFα upon drug-induced toxicity with in human, tissue-engineered myobundles.
title_fullStr Modeling the direct effects of TNFα upon drug-induced toxicity with in human, tissue-engineered myobundles.
title_full_unstemmed Modeling the direct effects of TNFα upon drug-induced toxicity with in human, tissue-engineered myobundles.
title_sort modeling the direct effects of tnfα upon drug-induced toxicity with in human, tissue-engineered myobundles.
publishDate 2016
url http://hdl.handle.net/10161/13357
work_keys_str_mv AT davisbrittany modelingthedirecteffectsoftnfaupondruginducedtoxicitywithinhumantissueengineeredmyobundles
_version_ 1718406330262224896